Brief: Shandong Boan Biotechnology Announces FY Loss Attributable Of RMB119.4 Mln
25/03/2024 14:09
March 25 (Reuters) - Shandong Boan Biotechnology Co Ltd
6955.HK :
* FY LOSS ATTRIBUTABLE RMB119.4 MILLION VERSUS LOSS RMB331.7
MILLION
* 2023 REVENUE RMB618.1 MLN VS RMB516.0 MLN
Further company coverage: 6955.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shandong Boan Biotechnology
See all newsBrief: Shandong Boan Biotechnology Says CDE Clears IND Application For BA1203
Brief: Shandong Boan Biotechnology Co Says Industrial Bank Financial Leasing Will Purchase Leased Assets From Co
Brief: Shandong Boan Biotechnology Announces CDE IND Application Acceptance For TLLA/IL-23 Bispecific Antibody BA2201
Brief: Shandong Boan Biotechnology Expects Net Loss Attributable Of RMB79 Million-RMB89 Million
Brief: Shandong Boan Biotechnology Submits BLA For BA9101 To Anvisa In Brazil